COVID-19, virus identified. COVID-19, virus identified
Conditions
Interventions
Intervention 1: Intervention group: The standard treatment for COVID-19 based on the Ministry of Health's protocol plus intratracheal epinephrine for intubated patients, and nebulizer form of epinephr
Sponsors
Bandare-abbas University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Months
Inclusion criteria
Inclusion criteria: Age between 18 and 80 years Positive polymerase chain reaction (PCR) test for COVID-19 Hospitalized Signing informed consent and willingness of study participant to accept randomization to any assigned treatment a
Exclusion criteria
Exclusion criteria: Contraindications epinephrine including, hemorrhagic CVA, TIA, and acute MI Heart rate > 100 History of allergy to epinephrine Pregnancy and breastfeeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical symptoms. Timepoint: Before intervention and daily during the study. Method of measurement: Questionnaire.;Oxygen saturation. Timepoint: Before intervention and daily during the study. Method of measurement: Pulse oximeter.;Pulmonary imaging finding. Timepoint: Before intervention and the fifth day of the study. Method of measurement: Computed tomography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of serious adverse events. Timepoint: Before intervention and daily during the study. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactParivash Davoodian
Bandare-abbas University of Medical Sciences
Outcome results
None listed